Could the Inhibition of Endo-Lysosomal Two-Pore Channels (TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS-CoV-2 Infection?
SARS-CoV, Anti-viral treatment, therapeutic targets, naringenin, endo-lysosomal dysfunction, two-pore channel (TPC)
Antonio Filippini, Antonella D'Amore, Fioretta Palombi, Armando Carpaneto, Armando Carpaneto